Even while data are not yet known about viral resistance to drugs orĀ their mutation potential, started the arribal of preventive studiesĀ based on the development of the common flu path and the evolution of “influenza A(N1H1)”, particularly in SouthAmerica. Particularly was Adecco who wrote the report which highlighted the next strong figures: the “influenza [...]

